Spineway to attend EUROSPINE 2025 in Copenhagen
Spineway, a specialist in innovative implants for the treatment of severe spine disorders, is announcing its participation in the EUROSPINE 2025 congress, to be held from October 22 to 24, 2025, in Copenhagen, Denmark.
A truly front-ranking international event, EUROSPINE brings together the leading players in spine surgery and care every year. The 2025 edition will be attended by more than 1,700 surgeons from over 20 countries, including Germany, Switzerland, Denmark, France, the United Kingdom and Spain.
Spineway’s 15th participation in Eurospine
Since 2006, Spineway has attended this major congress to showcase its product ranges and new offerings. At the 2025 edition, the Group will present its premium ranges: VEOS, KAPHORN, ACIFBOX and its ESP disc prostheses.
Demonstrations will be offered at the Spineway stand, allowing visiting surgeons to learn about the Group’s latest innovations.
A key opportunity for meetings and exchanges
EUROSPINE represents a unique opportunity for Spineway to meet its customers and distributors from Europe, Latin America, Asia, and the Middle East. These meetings provide an opportunity to discuss developments in product ranges, surgeons’ needs and the medical training projects supported by the Group. The event also provides an ideal setting to initiate new partnerships and strengthen Spineway’s international presence.
Spineway will take this opportunity to celebrate its 20th anniversary with its distributors and partners, commemorating two decades of innovation and commitment to spine surgery.
“EUROSPINE is a highlight for our Group each year. This year’s event will be particularly significant because it coincides with Spineway’s 20th anniversary. We look forward to sharing our latest innovations and continuing to develop ever more effective solutions for surgeons and their patients,” said Stéphane Le Roux, Spineway CEO.
Next event
January 13, 2026 – Full-year 2025 revenue
About Spineway
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and more than 70% of its revenue comes from exports.
Spineway is eligible for the PEA-PME (equity savings plans for SMEs)
Listing venue: Euronext Growth Paris
ISIN: FR001400N2P2
Ticker: ALSPW
Find out all about Spineway at www.spineway.com
Contacts
Spineway
Shareholder-services line
Available Tuesday through Thursday (10 a.m.-12 midday)
08 06 70 60 60
Aelium
Investor relations
Solène Kennis
spineway@aelium.fr
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.